211 related articles for article (PubMed ID: 25914945)
1. Mechanisms of drug release in nanotherapeutic delivery systems.
Wong PT; Choi SK
Chem Rev; 2015 May; 115(9):3388-432. PubMed ID: 25914945
[No Abstract] [Full Text] [Related]
2. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
3. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
Patra CR
Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
[No Abstract] [Full Text] [Related]
4. A yolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light.
Lv R; Yang P; He F; Gai S; Li C; Dai Y; Yang G; Lin J
ACS Nano; 2015 Feb; 9(2):1630-47. PubMed ID: 25581331
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
[TBL] [Abstract][Full Text] [Related]
6. Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond.
Mitragotri S; Lammers T; Bae YH; Schwendeman S; De Smedt S; Leroux JC; Peer D; Kwon IC; Harashima H; Kikuchi A; Oh YK; Torchilin V; Hennink W; Hanes J; Park K
J Control Release; 2017 Jan; 246():183-184. PubMed ID: 28110715
[No Abstract] [Full Text] [Related]
7. siRNA liposome-gold nanorod vectors for multispectral optoacoustic tomography theranostics.
Taruttis A; Lozano N; Nunes A; Jasim DA; Beziere N; Herzog E; Kostarelos K; Ntziachristos V
Nanoscale; 2014 Nov; 6(22):13451-6. PubMed ID: 25301102
[TBL] [Abstract][Full Text] [Related]
8. The drug delivery field needs a well-diversified technology portfolio.
Park K
J Control Release; 2017 Jan; 245():177. PubMed ID: 28065323
[No Abstract] [Full Text] [Related]
9. Silver Prussian blue analogue nanomedicine for future cancer therapy.
Haque S; Patra CR
Future Oncol; 2021 Jan; 17(2):119-122. PubMed ID: 33244991
[No Abstract] [Full Text] [Related]
10. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review.
Bayford R; Rademacher T; Roitt I; Wang SX
Physiol Meas; 2017 Jul; 38(8):R183-R203. PubMed ID: 28480874
[TBL] [Abstract][Full Text] [Related]
11. A Theranostic Two-Tone Luminescent PhotoCORM Derived from Re(I) and (2-Pyridyl)-benzothiazole: Trackable CO Delivery to Malignant Cells.
Carrington SJ; Chakraborty I; Bernard JM; Mascharak PK
Inorg Chem; 2016 Aug; 55(16):7852-8. PubMed ID: 27082125
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
Jiao Y; Sun Y; Tang X; Ren Q; Yang W
Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
[TBL] [Abstract][Full Text] [Related]
13. Phyto-nanotechnology in anti-aging medicine.
Vaiserman A; Koliada A; Lushchak O
Aging (Albany NY); 2021 Apr; 13(8):10818-10820. PubMed ID: 33910168
[No Abstract] [Full Text] [Related]
14. Smart nanotheranostic hydrogels for on-demand cancer management.
Misra R; Acharya S
Drug Discov Today; 2021 Feb; 26(2):344-359. PubMed ID: 33212236
[TBL] [Abstract][Full Text] [Related]
15. Combination drug release of smart cyclodextrin-gated mesoporous silica nanovehicles.
Zhou S; Sha H; Ke X; Liu B; Wang X; Du X
Chem Commun (Camb); 2015 Apr; 51(33):7203-6. PubMed ID: 25811958
[TBL] [Abstract][Full Text] [Related]
16. Boosting clinical translation of nanomedicine.
Jang HL; Zhang YS; Khademhosseini A
Nanomedicine (Lond); 2016 Jun; 11(12):1495-7. PubMed ID: 27176482
[No Abstract] [Full Text] [Related]
17. Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems.
McClements DJ
Adv Colloid Interface Sci; 2015 May; 219():27-53. PubMed ID: 25747522
[TBL] [Abstract][Full Text] [Related]
18. Q&A: Omid Farokhzad on Nanomedicine in Cancer.
Cancer Discov; 2016 Dec; 6(12):1300. PubMed ID: 27815294
[TBL] [Abstract][Full Text] [Related]
19. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery.
Popat A; Jambhrunkar S; Zhang J; Yang J; Zhang H; Meka A; Yu C
Chem Commun (Camb); 2014 May; 50(42):5547-50. PubMed ID: 24603852
[TBL] [Abstract][Full Text] [Related]
20. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
